Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
Your doctor discusses blood sugar targets with both
GLP-1 receptor agonist medications - including semaglutide (the active ingredient in Wegovy and Ozempic) and tirzepatide (the active ingredient in Zepbound and Mounjaro) - have transformed obesity treatment
Researchers told me they believe the drugs dampen or fine-tune the immune response, without the sledgehammer effect of steroids
Clinician partners practice through the Maximus Medical Group Practices affiliate and are listed on the patient-facing site
Karr, T., et al
HarrisMartin Publishing
US$ 29.65
US$ 24.50
US$ 24.32
US$ 27.74
US$ 29.05
US$ 23.14
